CIK 0001512762
- Accelerated filer
- Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273615821
- Phone
- +1 650-649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 4 Open-market sale President & CEO sold 223,100 shares at $2.02 ($449,770)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Scientific Officer gave up 16,278 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,451 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,457 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President & CEO acquired 86,250 shares (grant or award)
- 4 Grant or award McMichael Bryan J acquired 12,500 shares (grant or award)
Page 4 of 20 · 399 filings